Motor Development and Orthoses in Spinal Muscular Atrophy (SMA)
Assessment of Motor Development Related to Use of Orthoses in SMA II and III
1 other identifier
observational
80
1 country
1
Brief Summary
Spinal Muscular Atrophy (SMA) is neurodegenerative disease of anterior horn cells of spinal cord and represents the second more frequent pathology in childhood. According to the age of onset and the maximum motor function the disorder is classified in 4 types. Patients with SMA II and SMA III often use orthoses to achieve postural and dynamic functions. In this retrospective observational study the investigators describe the characteristics of sitting position, standing and walking correlated to type and time of orthoses used.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 17, 2009
CompletedFirst Posted
Study publicly available on registry
August 18, 2009
CompletedStudy Start
First participant enrolled
October 12, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
April 4, 2011
CompletedDecember 23, 2025
September 1, 2025
20 days
August 17, 2009
December 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
time and percentage of sitting, standing, walking achievement in SMA II and SMA III
aug.2009- nov.2009
Secondary Outcomes (1)
characteristics and percentage of orthoses for postural sitting control , standing and walking in SMA II and SMA III
aug. 2009 - dec.2009
Study Arms (1)
SMA II and SMA III
patients with SMA II and SMA III
Eligibility Criteria
patients with SMA II and SMA III referred to UDGEE for rehabilitation consultation
You may qualify if:
- Clinical and genetics diagnosis of SMA II and SMA III
You may not qualify if:
- N/A
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UDGEE Hospital S.Maria Nuova
Reggio Emilia, RE, 42100, Italy
Related Publications (1)
Wang CH, Finkel RS, Bertini ES, Schroth M, Simonds A, Wong B, Aloysius A, Morrison L, Main M, Crawford TO, Trela A; Participants of the International Conference on SMA Standard of Care. Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol. 2007 Aug;22(8):1027-49. doi: 10.1177/0883073807305788.
PMID: 17761659BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Adriano Ferrari, MD
Hospital S.Maria Nuova Reggio Emilia Italy
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 17, 2009
First Posted
August 18, 2009
Study Start
October 12, 2009
Primary Completion
November 1, 2009
Study Completion
April 4, 2011
Last Updated
December 23, 2025
Record last verified: 2025-09